New! Sign up for our email newsletter on Substack.

Matching patient’s molecular profile with current evidence on targeted anticancer therapy

Investigators of the Melanoma Molecular Map Project (MMMP, www.mmmp.org) have proposed a new databank entitled “TARGETED THERAPY DATABASE-TTD” along with a method to match the patient’s molecular profile with the available evidence on targeted anti-melanoma therapy.
Both the database and the algorithm for the profile matching are freely available at the following address:

http://www.mmmp.org/MMMP/import.mmmp?page=targetedtherapydatabase.mmmp

I found this initiative extremely interesting as it might represent the template for similar databanks dedicated to other diseases !

cheers
William

Fuel Independent Science Reporting: Make a Difference Today

If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.

Join us in making knowledge accessible and impactful. Thank you for standing with us!



1 thought on “Matching patient’s molecular profile with current evidence on targeted anticancer therapy”

  1. The Targeted Therapy Database (TTD) has been recently complemented with the TARGETED THERAPY ANALYZER (TTA), a computational tool for the automated analysis of the data collected in the TTD.
    The TTA enables users to easily implement the algorithms necessary to summarize the literature data and to match the tumor/patient molecular profile with the available evidence on the molecularly targeted therapy of melanoma.
    You can find both tools on the Melanoma Molecular Map Project website (www.mmmp.org).

    Reply

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.